BioSens8 is a biotech company that senses beyond glucose to enable holistic health monitoring and offers health monitoring products.
BioSens8 has raised $100K in total funding. The most recent round was Grant. The last funding was announced in May 2024.
BioSens8's investors include National Science Foundation, MassChallenge, MassVentures.
BioSens8 is headquartered in Cambridge, United States.
BioSens8 is a biotech company that senses beyond glucose to enable holistic health monitoring and offers health monitoring products.
BioSens8 is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioSens8 — Funding & Investors." VCBacked, May 22, 2024, https://www.vcbacked.co/company/biosens8. Accessed July 20, 2026.
VCBacked. (2024). BioSens8 — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biosens8
{{cite web |title=BioSens8 — Funding & Investors |url=https://www.vcbacked.co/company/biosens8 |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated